Evaluation of Intraocular Pressure Changes Following Trabeculectomy with Mitomycin-C (MMC): A One-Year Follow-Up Study at Undaan Eye Hospital, Indonesia
Downloads
Introduction: Trabeculectomy with mitomycin-C (MMC) is a widely used surgical intervention for the management of glaucoma. This study aimed to evaluate changes in intraocular pressure (IOP) before and after surgery, using statistical analyses of pre-operative and post-operative IOP measurements. Purpose: To determine the effectiveness of MMC in trabeculectomy and its role in enhancing surgical success. Methods: This retrospective observational study analyzed the medical records of 65 eyes from 52 glaucoma patients who underwent trabeculectomy with 2% MMC at Undaan Eye Hospital, Surabaya, Indonesia, between 2022 and 2023. Post-operative IOP was assessed at one, three, six, and twelve months. Statistical analyses were performed to identify patterns of IOP change over time. Results: A Kruskal-Wallis test, followed by Dunn's post hoc analysis (p < 0.001), revealed significant differences in IOP between the pre-operative and post-operative periods (p < 0.05). However, no significant differences were found among post-operative follow-up intervals (p > 0.05). Correlation analysis of IOP categories (< 20 mmHg vs. ≥ 20 mmHg) across observation points showed a negative correlation (r = -0.491, p < 0.001), indicating a tendency for IOP reduction over time. Regression analysis estimated that IOP decreased by approximately 1.141 mmHg per month. Conclusions: Significant reductions in IOP were observed post-operatively, with a sustained downward trend compared to pre-operative values. These findings provide valuable insights into the long-term effectiveness of trabeculectomy with MMC, emphasizing factors that optimize surgical outcomes for glaucoma management.
Bell K, de Padua Soares Bezerra B, Mofokeng M, Montesano G, Nongpiur ME, Marti MV, et al. Learning from the past: Mitomycin C use in trabeculectomy and its application in bleb-forming minimally invasive glaucoma surgery. Surv Ophthalmol 2021;66:109–123. https://doi.org/10.1016/j.survophthal.2020.05.005.
Khan SA, Whittaker K, Razzaq MA, Arain UR. National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK. Int Ophthalmol 2021;41:1309–1316. https://doi.org/10.1007/s10792-020-01688-8.
Zaidi AA. Trabeculectomy: A review and 4-year follow-up. Br J Ophthalmol 1980;64:436–439. https://doi.org/10.1136/bjo.64.6.436.
Edward D, Al Habash A, Aljasim L, Owaidhah O. A review of the efficacy of mitomycin C in glaucoma filtration surgery. Clinical Ophthalmology 2015:1945. https://doi.org/10.2147/OPTH.S80111.
Vinod K, Gedde SJ, Feuer WJ, Panarelli JF, Chang TC, Chen PP, et al. Practice preferences for glaucoma surgery: A survey of the American Glaucoma Society. J Glaucoma 2017;26:687–693. https://doi.org/10.1097/IJG.0000000000000720.
Allison K, Patel D, Alabi O. Epidemiology of Glaucoma: The past, present, and predictions for the future. Cureus 2020. https://doi.org/10.7759/cureus.11686.
Seth PK, Senthil S, Das AV, Garudadri C. Prevalence of glaucoma types, clinical profile and disease severity at presentation: Tertiary Institute based cross-sectional study from South India. Indian J Ophthalmol 2023;71:3305–3312. https://doi.org/10.4103/IJO.IJO_3305_22.
Wagner IV, Stewart MW, Dorairaj SK. Updates on the diagnosis and management of glaucoma. Mayo Clin Proc Innov Qual Outcomes 2022;6:618–635. https://doi.org/10.1016/j.mayocpiqo.2022.09.007.
Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int 2020. https://doi.org/10.3238/arztebl.2020.0225.
Cvenkel B, Kolko M. Devices and treatments to address low adherence in glaucoma patients: A narrative review. J Clin Med 2022;12:151. https://doi.org/10.3390/jcm12010151.
Almobarak FA, Alharbi AH, Morales J, Aljadaan I. The influence of mitomycin C concentration on the outcome of trabeculectomy in uveitic glaucoma. Int Ophthalmol 2018;38:2371–2379. https://doi.org/10.1007/s10792-017-0737-6.
Song ZH, Xu SS, Li GY, Wang ET, Li Y, Zhang C. Efficacy and safety of the intraoperative application of mitomycin in glaucoma patients with trabeculectomy: A systematic review and meta-analysis. J Clin Pharm Ther 2023;2023:1–11. https://doi.org/10.1155/2023/5249552.
He M, Wang W, Zhang X, Huang W. Ologen implant versus mitomycin C for trabeculectomy: A systematic review and meta-analysis. PLoS One 2014;9:e85782. https://doi.org/10.1371/journal.pone.0085782.
Song D-S, Qian J, Chen Z-J. Ologen implant versus mitomycin-C for trabeculectomy. Medicine 2019;98:e16094. https://doi.org/10.1097/MD.0000000000016094.
Sari YP, Ekantini R, Gani TT, Jati KDP. Intraoperative mitomycin-c, 5-fluorouracil, retrobulbar triamcinolon acetonide, is it equally effective to decrease intra ocular pressure after trabeculectomy? Ophthalmol Indones 2024;49. https://doi.org/10.35749/4e85px09.
Yuasa Y, Sugimoto Y, Hirooka K, Ohkubo S, Higashide T, Sugiyama K, et al. Effectiveness of trabeculectomy with mitomycin C for glaucomatous eyes with low intraocular pressure on treatment eye drops. Acta Ophthalmol 2020;98. https://doi.org/10.1111/aos.14195.
Romero P, Hirunpatravong P, Alizadeh R, Kim E-A, Nouri-Mahdavi K, Morales E, et al. Trabeculectomy with mitomycin-C: Outcomes and risk factors for failure in primary angle-closure glaucoma. J Glaucoma 2018;27:101–107. https://doi.org/10.1097/IJG.0000000000000842.
Maheshwari D, Kanduri S, Kadar M, Ramakrishnan R, Pillai M. Midterm outcome of mitomycin C augmented trabeculectomy in open angle glaucoma versus angle closure glaucoma. Indian J Ophthalmol 2019;67:1080. https://doi.org/10.4103/ijo.IJO_1328_18.
Cumurcu T. Mitomycin-C use and complications in ophthalmology. Inter J Clin Exp Ophthalmol 2017;1:29–32. https://doi.org/10.29328/journal.hceo.1001004.
Musch DC, Gillespie BW, Niziol LM, Cashwell LF, Lichter PR. Factors associated with intraocular pressure before and during 9 years of treatment in the collaborative initial glaucoma treatment study. Ophthalmology 2008;115:927–933. https://doi.org/10.1016/j.ophtha.2007.08.010.
Hoang TKH, Kim YK, Jeoung JW, Park KH. Relationship between age and surgical success after trabeculectomy with adjunctive mitomycin C. Eye 2018;32:1321–1328. https://doi.org/10.1038/s41433-018-0071-x.
Birla S, Varshney T, Singh A, Sharma A, Panigrahi A, Gupta S, et al. Machine learning-assisted prediction of trabeculectomy outcomes among patients of juvenile glaucoma by using 5-year follow-up data. Indian J Ophthalmol 2024;72:987–993. https://doi.org/10.4103/IJO.IJO_2009_23.
Lee S, Park DY, Huh MG, Cha SC. Influence of preoperative glaucoma medication on long-term outcomes of trabeculectomy. Sci Rep 2024;14:28341. https://doi.org/10.1038/s41598-024-79637-z.
Qin Z-X, Han Q, Wang L, Tan L, Xu Y-F, You Q-X, et al. Outcomes and risk factors for failure of trabeculectomy in glaucomatous patients in Southwest China: A 325 eyes analysis. Int J Ophthalmol 2023;16:367–374. https://doi.org/10.18240/ijo.2023.03.06.
Copyright (c) 2025 Raudhatuzzahra Kesuma, Lydia Nuradianti, Debby Soraya, Rizna Audina
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
